The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study
Abstract
Background— Elevated lipoprotein(a) levels are associated with myocardial infarction (MI) in some but not all studies. Limitations of previous studies include lack of risk estimates for extreme lipoprotein(a) levels, measurements in long-term frozen samples, no correction for regression dilution bias, and lack of absolute risk estimates in the general population. We tested the hypothesis that extreme lipoprotein(a) levels predict MI in the general population, measuring levels shortly after sampling, correcting for regression dilution bias, and calculating hazard ratios and absolute risk estimates. Methods and Results— We examined 9330 men and women from the general population in the Copenhagen City Heart Study. During 10 years of follow-up, 498 participants developed MI. In women, multifactorially adjusted hazard ratios for MI for elevated lipoprotein(a) levels were 1.1 (95% CI, 0.6 to 1.9) for 5 to 29 mg/dL (22nd to 66th percentile), 1.7 (1.0 to 3.1) for 30 to 84 mg/dL (67th to 89th percentile), 2.6 (1.2 to 5.9) for 85 to 119 mg/dL (90th to 95th percentile), and 3.6 (1.7 to 7.7) for ≥120 mg/dL (>95th percentile) versus levels <5 mg/dL (<22nd percentile). Equivalent values in men were 1.5 (0.9 to 2.3), 1.6 (1.0 to 2.6), 2.6 (1.2 to 5.5), and 3.7 (1.7 to 8.0). Absolute 10-year risks of MI were 10% and 20% in smoking, hypertensive women aged >60 years with lipoprotein(a) levels of <5 and ≥120 mg/dL, respectively. Equivalent values in men were 19% and 35%. Conclusions— We observed a stepwise increase in risk of MI with increasing levels of lipoprotein(a), with no evidence of a threshold effect. Extreme lipoprotein(a) levels predict a 3- to 4-fold increase in risk of MI in the general population and absolute 10-year risks of 20% and 35% in high-risk women and men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The mysteries of lipoprotein(a).
Utermann, G. (1989) · Science · doi:10.1126/science.2530631 · Cited by 1,257
Sharrett, A. R., Ballantyne, C. M., Coady, S. A., Heiss, G., Sorlie, P. D., Catellier, D., & Patsch, W. (2001) · Circulation · doi:10.1161/hc3501.095214 · Cited by 944
Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043175 · Cited by 784
CARLSON, L. A., HAMSTEN, A., & ASPLUND, A. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb01393.x · Cited by 443
Marcovina, S. M., Albers, J. J., Gabel, B., Koschinsky, M. L., & Gaur, V. P. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.2.246 · Cited by 354
Jenner, J. L., Ordovas, J. M., Lamon-Fava, S., Schaefer, M. M., Wilson, P. W., Castelli, W. P., & Schaefer, E. J. (1993) · Circulation · doi:10.1161/01.cir.87.4.1135 · Cited by 338
Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study
Chambless, L. E., Folsom, A. R., Sharrett, A. R., Sorlie, P., Couper, D., Szklo, M., & Nieto, F. J. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00055-6 · Cited by 307
Effects of Lowering Elevated LDL Cholesterol on the Cardiovascular Risk of Lipoprotein(a)
Maher, V. M. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220037029 · Cited by 298
Marcovina, S. M., Koschinsky, M. L., Albers, J. J., & Skarlatos, S. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.023689 · Cited by 288
Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly
Ariyo, A. A., Thach, C., & Tracy, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa001066 · Cited by 288
Apolipoproteins and ischaemic heart disease: implications for screening
Wald, N., Watt, H., Bailey, A., Johnson, M., Ledue, T. B., & Haddow, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90814-1 · Cited by 241
Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study
Luc, G., Bard, J.-M., Arveiler, D., Ferrieres, J., Evans, A., Amouyel, P., Fruchart, J.-C., & Ducimetiere, P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00026-6 · Cited by 227
Suk Danik, J., Rifai, N., Buring, J. E., & Ridker, P. M. (2006) · JAMA · doi:10.1001/jama.296.11.1363 · Cited by 216
Rader, D. J., Hoeg, J. M., & Brewer, H. B. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-12-199406150-00008 · Cited by 216
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies
Craig, W. Y., Neveux, L. M., Palomaki, G. E., Cleveland, M. M., & Haddow, J. E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.11.2301 · Cited by 210
Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population
Juul, K., Tybjærg-Hansen, A., Schnohr, P., & Nordestgaard, B. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00008 · Cited by 195
Self-citationvon Eckardstein, A., Schulte, H., Cullen, P., & Assmann, G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01126-8 · Cited by 187
American association for clinical chemistry
(1981) · Gene · doi:10.1016/0378-1119(81)90119-0 · Cited by 178
Boffa, M. B., Marcovina, S. M., & Koschinsky, M. L. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.12.007 · Cited by 172
The Copenhagen city heart study
Kofoeda, S. C., Wittrupb, H. H., Sillesena, H., & Nordestgaardb, B. G. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90110-5 · Cited by 162
Cantin, B., Gagnon, F., Moorjani, S., Després, J., Lamarche, B., Lupien, P. J., & Dagenais, G. R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00528-7 · Cited by 152
Determinants of severity of coronary artery disease in Australian men and women.
Wang, X.-L., Tam, C., Mccredie, R., & Wilcken, D. (1994) · Circulation · doi:10.1161/01.cir.89.5.1974 · Cited by 143
Rifai, N., Ma, J., Sacks, F. M., Ridker, P. M., Hernandez, W. J. L., Stampfer, M. J., & Marcovina, S. M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.030031 · Cited by 127
Schnohr, P. (2001) · European Heart Journal Supplements · Cited by 116
Lipoprotein(a) in Stored Plasma Samples and the Ravages of Time
Kronenberg, F., Trenkwalder, E., Dieplinger, H., & Utermann, G. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1568 · Cited by 101
Lipoprotein(a): New insights into mechanisms of atherogenesis and thrombosis
Deb, A., & Caplice, N. M. (2004) · Clinical Cardiology · doi:10.1002/clc.4960270503 · Cited by 99
Cantin, B., Després, J., Lamarche, B., Moorjani, S., Lupien, P. J., Bogaty, P. M., Bergeron, J., & Dagenais, G. R. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02336-0 · Cited by 92
Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a)
SEMAN, L. J., & Breckenridge, W. C. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-133 · Cited by 91
Tate, J. R., Rifai, N., Berg, K., Couderc, R., Dati, F., Kostner, G. M., Sakurabayashi, I., & Steinmetz, A. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1629 · Cited by 72
Specific Accumulation of Lipoprotein(a) in Balloon-Injured Rabbit Aorta In Vivo
Nielsen, L. B., Stender, S., Kjeldsen, K., & Nordestgaard, B. G. (1996) · Circulation Research · doi:10.1161/01.res.78.4.615 · Cited by 68
Self-citationIn Vivo Transfer of Lipoprotein(a) Into Human Atherosclerotic Carotid Arterial Intima
Nielsen, L. B., Grønholdt, M.-L. M., Schroeder, T. V., Stender, S., & Nordestgaard, B. G. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.5.905 · Cited by 63
Self-citationNielsen, L. B., Stender, S., Jauhiainen, M., & Nordestgaard, B. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118824 · Cited by 48
Self-citationNielsen, L. B., Juul, K., & Nordestgaard, B. G. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.4.641 · Cited by 44
Self-citationTransfer of Lipoprotein(a) and LDL Into Aortic Intima in Normal and in Cholesterol-Fed Rabbits
Nielsen, L. B., Nordestgaard, B. G., Stender, S., Niendorf, A., & Kjeldsen, K. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1492 · Cited by 36
Self-citationHemostatic Factors as Predictors of Coronary Events and Total Mortality
Salomaa, V. V., Rasi, V., Kulathinal, S., Vahtera, E. M., Jauhiainen, M., Ehnholm, C., & Pekkanen, J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.104078 · Cited by 32
Bateman, T. M., Case, J. A., Cullom, S. J., Bamhart, C., & O’Keefe, J. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)80614-1 · Cited by 8
Cited by
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
Self-citation(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac361 · Cited by 1,449
Self-citationGenetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357
Self-citationLoss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919
Self-citation
Metadata
- Authors
- Kamstrup, P. R., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G.
- Venue
- Circulation
- Published
- 2008-01-15
- Volume
- 117
- Issue
- 2
- Pages
- 176-184
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1988163135
- Cited by
- 558
- References
- 39
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.